Singapore's Food Agency published a complete list of 14 approved novel foods, including four cultivated meat products and seven fermentation-based ingredients — even as the country quietly deprioritizes alternative proteins in its national food strategy.
Here's the most telling detail from Singapore's newly published alternative protein scorecard: fermentation-based products outnumber cultivated meat approvals. The country that made global headlines for greenlighting lab-grown chicken has quietly built a deeper regulatory bench in a technology most consumers have never heard of — and that gap between perception and reality reveals something important about where alternative protein actually stands.
The Singapore Food Agency (SFA) has published a complete list of novel foods it has greenlit for sale, as reported by Green Queen. The regulatory document reads like a timeline of food tech firsts. But it also reads like an argument: the most commercially viable alternative protein pathway isn't the one that dominates headlines. Fermentation is doing the heavier lifting, and Singapore's own regulatory record proves it.
That argument matters now because Singapore's relationship with alternative protein is entering a more complicated phase. According to Green Queen, alternative proteins have reportedly been de-emphasized in Singapore's national food strategy. Environment Minister Grace Fu has reportedly pointed to higher production costs and weaker-than-expected consumer acceptance globally as factors. The country is now redirecting focus toward R&D to make the sector more competitive rather than rushing to commercialize.
So the list drops at an odd moment — regulatory confidence alongside policy hesitation. And the composition of that list suggests the government may already know which technology has the shorter path to commercial reality.
The cultivated meat approvals: prestigious but narrow
Multiple cultivated meat products have received approval. Two belong to Eat Just's Good Meat brand: an early chicken clearance that made global headlines, and a later follow-up for a serum-free version.
Australian startup Vow received approval for its cultured quail. The product has since been commercialised in dishes including parfaits and foie gras, and is currently available in multiple locations across Singapore, according to Green Queen's reporting.
Also in the cultivated category: Parima, the company formed from the merger of French startups Gourmey and Vital Meat. Its cultivated chicken was recently approved. Parima has reportedly also earned the go-ahead for Gourmey's cultivated duck, which the company plans to introduce through haute cuisine channels before a retail rollout.
An unnamed industry leader quoted by Green Queen suggested up to a dozen additional cultivated meat companies are still awaiting approval in Singapore. But the pattern is clear: cultivated meat remains confined largely to restaurants and tasting events. These are regulatory milestones, not commercial ones.
Fermentation: the quieter, larger story
A majority of the approvals are fermentation-based, and unlike cultivated meat, several of these products have already found their way into everyday consumer formats — gelato, lattes, mooncakes, pasta, ice cream sandwiches.
Early novel food approvals from the SFA went to Triton Algae Innovations for algae ingredients. Nature's Fynd's Fy protein, a fungal strain with origins in research related to Yellowstone National Park, also received approval.
Solar Foods' Solein, the yellow powder made by feeding microbes carbon and other gases rather than sugar, also made the list. It has appeared in products across the country. We've previously covered the broader category of gas-fermented proteins made from waste carbon.
Additional mycoprotein approvals have been granted to companies including The Better Meat Co's Rhiza and Fermotein from Dutch startup The Protein Brewery. An approval for a mycelium ingredient derived from the Pleurotus pulmonarius strain (the phoenix mushroom) also appears on the list, though Green Queen notes the responsible startup hasn't been publicly identified.
The breadth here is what matters. Fermentation-based proteins span multiple production methods — precision fermentation, biomass fermentation, gas fermentation — and they're arriving at commercial scale faster because the underlying bioreactor technology is already proven in pharmaceuticals and food ingredient manufacturing. Cultivated meat requires building an entirely new production infrastructure from scratch. Singapore's approval list makes that asymmetry visible in a way that industry pitch decks rarely do.
Why the list matters: regulatory leadership as strategy
Publishing a consolidated novel foods list is a small bureaucratic act with real consequences. It gives food companies, investors and importers a single source of truth, and it signals that Singapore still wants to be the jurisdiction where alt-protein companies file their first regulatory package, even if domestic commercialisation has slowed.
That distinction matters. Regulatory leadership and market leadership aren't the same thing. Italy has reportedly moved in the opposite direction by restricting cultivated meat. Singapore is keeping the door open while publicly acknowledging the economics aren't working yet — a pragmatic bet that being the first regulatory safe harbour will pay dividends when costs eventually come down.
For readers tracking what's actually on plates, the takeaway is narrower than the hype cycle suggests. Several cultivated products, mostly in restaurants. Multiple fermentation ingredients, quietly showing up in everyday foods. Singapore has also been stockpiling high-protein crops as a separate food security play, which tells you where the government thinks the near-term resilience actually lives.
The cultivated meat story isn't over. It's just on a longer clock than anyone wanted. And in the meantime, fermentation — less cinematic, less controversial, less expensive — is quietly becoming the alternative protein technology that actually ships.
